Clinical trial
Patient Specific Optimized Therapy (PSOT) in Atrial Flutter Population Miami Cardiac & Vascular Institute (MCVI) Post Marketing Surveillance (PMS) Study
NCT03858361 is registered in ClinicalTrials.gov with EPD Solutions, A Philips Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Specific Optimized Therapy (PSOT) in Atrial Flutter Population Miami Cardiac & Vascular Institute (MCVI) Post Marketing Surveillance (PMS) Study
- Lead sponsor
- EPD Solutions, A Philips Company
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 13, 2019
- Completion date
- March 28, 2023
- Enrollment
- 566 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
data collection